Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.

Quigley EA, Halpern AC.

Am J Clin Dermatol. 2013 Apr;14(2):125-37. doi: 10.1007/s40257-013-0012-1. Review.

PMID:
23479385
2.

Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.

Florin V, Desmedt E, Vercambre-Darras S, Mortier L.

Invest New Drugs. 2012 Aug;30(4):1641-5. doi: 10.1007/s10637-011-9717-2. Epub 2011 Jul 13.

PMID:
21748297
3.

100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.

Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E.

J Am Acad Dermatol. 2015 Oct;73(4):645-54. doi: 10.1016/j.jaad.2015.06.060. Epub 2015 Aug 7.

4.

Interventions for melanoma in situ, including lentigo maligna.

Tzellos T, Kyrgidis A, Mocellin S, Chan AW, Pilati P, Apalla Z.

Cochrane Database Syst Rev. 2014 Dec 19;(12):CD010308. doi: 10.1002/14651858.CD010308.pub2. Review.

PMID:
25526608
5.

Chemotherapy and biologic therapies for melanoma: do they work?

Jilaveanu LB, Aziz SA, Kluger HM.

Clin Dermatol. 2009 Nov-Dec;27(6):614-25. doi: 10.1016/j.clindermatol.2008.09.020. Review.

PMID:
19880049
6.

Clearance of invasive melanoma with topical imiquimod.

Moon SD, Spencer JM.

J Drugs Dermatol. 2013 Jan;12(1):107-8.

PMID:
23377337
7.

[Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].

Loquai C, Nashan D, Metze D, Beiteke U, RĂ¼ping KW, Luger TA, Grabbe S.

Hautarzt. 2004 Feb;55(2):176-81. German.

PMID:
14968329
8.

Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.

Garcia MS, Ono Y, Martinez SR, Chen SL, Goodarzi H, Phan T, Wehrli LN, Miyamura Y, Fung MA, Maverakis E.

Melanoma Res. 2011 Jun;21(3):235-43. doi: 10.1097/CMR.0b013e328345e95e.

PMID:
21464773
9.

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.

Green DS, Bodman-Smith MD, Dalgleish AG, Fischer MD.

Br J Dermatol. 2007 Feb;156(2):337-45.

PMID:
17223875
10.
11.
12.

Melanoma in situ: Part II. Histopathology, treatment, and clinical management.

Higgins HW 2nd, Lee KC, Galan A, Leffell DJ.

J Am Acad Dermatol. 2015 Aug;73(2):193-203; quiz 203-4. doi: 10.1016/j.jaad.2015.03.057. Review.

PMID:
26183968
13.

Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.

Ellis LZ, Cohen JL, High W, Stewart L.

Dermatol Surg. 2012 Jun;38(6):937-46. doi: 10.1111/j.1524-4725.2012.02362.x. Epub 2012 Feb 16.

PMID:
22338583
14.

Treatment of locally metastatic melanoma: a novel approach.

Shistik G, Prakash AV, Fenske NA, Glass LF.

J Drugs Dermatol. 2007 Aug;6(8):830-2.

PMID:
17763615
15.

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.

Keilholz U, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, Thomas J, Proebstle TM, Schmittel A, Schadendorf D, Velu T, Negrier S, Kleeberg U, Lehman F, Suciu S, Eggermont AM.

J Clin Oncol. 2005 Sep 20;23(27):6747-55.

PMID:
16170182
16.

Topical imiquimod in the treatment of metastatic melanoma to skin.

Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H.

Arch Dermatol. 2003 Mar;139(3):273-6. No abstract available.

PMID:
12622616
17.

Cutaneous melanoma: available therapy for metastatic disease.

Tarhini AA, Agarwala SS.

Dermatol Ther. 2006 Jan-Feb;19(1):19-25. Review.

PMID:
16405566
18.

Adjuvant therapy in melanoma.

Mohr P, Weichenthal M, Hauschild A.

Onkologie. 2003 Jun;26(3):227-33. Review.

PMID:
12845206
19.

Malignant melanoma: non-metastatic.

Crosby D, Crosby T, Mason M.

Clin Evid. 2002 Jun;(7):1519-29. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):1842-53.

PMID:
12230768
20.

[Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].

Florin V, Vercambre-Darras S, Piette F, Mortier L.

Ann Dermatol Venereol. 2008 Aug-Sep;135(8-9):603-4. doi: 10.1016/j.annder.2008.04.008. Epub 2008 Jul 3. French. No abstract available.

PMID:
18789300

Supplemental Content

Support Center